Arabidopsis cryptochrome 2 (CRY2) is a blue light receptor that mediates light inhibition of hypocotyl elongation and long-day promotion of floral initiation. CRY2 is known to undergo blue light-dependent phosphorylation, which is believed to serve regulatory roles in the function of CRY2. We report here on a biochemical and genetics study of CRY2 phosphorylation. Using mass spectrometry analysis, we identified three serine residues in the CCE domain of CRY2 (S588, S599, and S605) that undergo blue light-dependent phosphorylation in Arabidopsis seedlings. A study of serine-substitution mutations in the CCE domain of CRY2 demonstrates that CRY2 contains two types of phosphorylation in the CCE domain, one in the serine cluster that causes electrophoretic mobility upshift and the other outside the serine cluster that does not seem to cause mobility upshift. We showed that mutations in the serine residues within and outside the serine cluster diminished blue light-dependent CRY2 phosphorylation, degradation, and physiological activities. These results support the hypothesis that blue light-dependent phosphorylation of the CCE domain determines the photosensitivity of Arabidopsis CRY2.
INTRODUCTION
Cryptochromes are photolyase-related blue light receptors that regulate photomorphogenesis in plants and the circadian clock in plants and animals (Cashmore, 2003; Lin and Shalitin, 2003; Sancar, 2003; Chaves et al., 2011) . The Arabidopsis genome encodes two cryptochromes, cryptochrome 1 (CRY1, 681 amino acids) and cryptochrome 2 (CRY2, 621 amino acids), which mediate overlapping blue light responses, such as inhibition of hypocotyl elongation and promotion of floral initiation (Ahmad and Cashmore, 1993; Guo et al., 1998; Lin et al., 1998) . Although the mechanism of the initial photochemistry of cryptochromes remains unclear, the signaling mechanism of plant cryptochromes is believed to involve light regulation of transcription and protein stability. For example, photoexcited CRY2 interacts with the bHLH transcription factors CIBs (CRY-Interacting BHLHs) to directly modulate transcription in Arabidopsis, and CRY2 also interacts with SPA1 (Suppressor of Phytochrome A 1) and COP1 (Constitutive Photomorphogenesis 1) to alter the stability of transcription factors required for the light-dependent transcriptional changes and photomorphogenesis (Wang et al., 2001; Yang et al., 2001; Liu et al., 2008 Liu et al., , 2011a Liu et al., , 2011b Zuo et al., 2011; Liu et al., 2013; Meng et al., 2013) .
Cryptochromes are characterized by two domains, the PHR (Photolyase Homologous Region) domain (about 500 residues), which is evolutionarily conserved in DNA photolyases and cryptochromes, and the CCE (CRY C-terminal Extension) domain (also referred to as the CCT domain), which is absent in photolyases . The CCE domains of cryptochromes in plants and animals share little sequence similarity, but they are intrinsically disordered yet functionally indispensable for cryptochromes in both evolutionary branches (Yang et al., 2000; Rosato et al., 2001; Zhu et al., 2003; Busza et al., 2004; Partch et al., 2005; Chaves et al., 2006; Yu et al., 2007b) . Cryptochromes are phosphoproteins and protein phosphorylation is believed to play important roles in the function and regulation of cryptochromes in both plants and animals (Shalitin et al., 2002 Lamia et al., 2009) . Arabidopsis cryptochromes appear to be phosphorylated in multiple residues of at least the CCE domain (Shalitin et al., 2002; Harada et al., 2005; Yu et al., 2007b) . Phosphorylation of the CCE domain correlates with the function of CRY2 (Yang et al., 2000; Shalitin et al., 2002; Sang et al., 2005) . For example, the GUS (b-glucuronidase)-CCT2 fusion protein, which contains the CCE domain without the PHR domain of CRY2, is constitutively phosphorylated, constitutively dimerized, and constitutively active in plants. Interestingly, the GFP (green fluorescent protein)-CRY2-N563 fusion protein (GFP-N563), which contains the N-terminal 563 residues but misses the serine-rich C-terminal half (49 residues) of the CCE domain of CRY2, remained photo-phosphorylated without mobility upshift , implying that CRY2 undergoes two types of photo-phosphorylation; one type of CRY2 phosphorylation causes mobility upshift, whereas the other type does not cause mobility upshift. It has been reported recently that Casein kinase 1 CK1.3 and CK1.4 phosphorylate CRY2 at serine 587 (S587) and threonine 603 (T603) to affect the function and regulation of CRY2 (Tan et al., 2013) . These observations are consistent with the hypothesis that blue lightinduced phosphorylation determines the function and regulation of CRY2 (Shalitin et al., 2002) . However, the in vivo phosphorylation sites of cryptochromes have not been identified in any plant cryptochromes, and how protein phosphorylation at different residues of plant cryptochromes affects their function and regulation remains unclear. To address these questions, we investigated the phosphorylatable residues of CRY2 by mass spectrometry (MS) analysis of CRY2 purified from plants, and we also systematically analyzed serine-substitution mutants of CRY2 in transgenic Arabidopsis. The results of these experiments demonstrate that CRY2 undergoes blue light-dependent phosphorylation in multiple serine residues of the CCE domain, including S598, S599, and S605, and that the combined phosphorylation pattern of CRY2 determines the photosensitivity of the physiological activities and blue light regulation of CRY2.
RESULTS

Identification of Blue Light-Dependent Phosphorylation Sites of CRY2 by Mass Spectrometry
To identify the blue light-induced phosphorylation sites of CRY2 in vivo, we purified and analyzed the GFP-CRY2 recombinant protein from the transgenic Arabidopsis plants (Yu et al., 2009) . We have previously shown that GFP-CRY2 is functionally indistinguishable from the endogenous CRY2 protein in all the photophysiological and photobiochemical properties examined (Yu et al., 2009 ). The GFP-CRY2 protein was purified from 7-dayold etiolated seedlings without (D) or with a brief blue light treatment (B30, 50 mmol m À2 s À1 for 30 min), using GFP-trap affinity chromatography ( Figure 1A ) (Rothbauer et al., 2008) . Similar to the endogenous CRY2, the GFP-CRY2 recombinant proteins in etiolated seedlings exposed to blue light exhibit electrophoretic mobility upshift and a reduced level of protein, which are due to blue light-dependent CRY2 phosphorylation, ubiquitination, and degradation ( Figure 1A ) Shalitin et al., 2002; Yu et al., 2007a) . We analyzed the light-dependent phosphorylation of the GFP-CRY2 protein purified from plants using label-free quantitative MS (see Methods). This MS experiment detected a phosphopeptide of CRY2, NLEGIQDSSDQITTSLGK (spectral false discovery rate <0.05), which is monophosphorylated or diphosphorylated at three residues: S598, S599, and S605 ( Figure 1B -1D, Supplemental Figures 1-3, and Supplemental Table 1 ). This is the first time that the blue light-dependent phosphorylation sites of a cryptochrome have been determined directly from the cryptochrome protein purified from plants.
Although additional phosphorylation sites of CRY2 were also identified in this experiment (Liu, 2015) , we focused on analysis of the phosphopeptide NLEGIQDSSDQITTSLGK in the present report. Figure 1C shows four different phosphorylation events detected in this phosphopeptide of CRY2 that exhibited clear blue light responsiveness, among which S598/S605 diphosphorylation exhibits a markedly higher blue light responsiveness than that of the monophosphorylation events in any neighboring serine residue of this phosphopeptide. This result appears to suggest that the blue light-dependent monophospohorylation facilitates further phosphorylation of the neighboring serine residues in this region of CRY2.
Expression and Subcellular Localization of the Serine-Substitution CRY2 Mutants in Transgenic Arabidopsis Plants
To further investigate photo-phosphorylation of CRY2, we performed a systematic analysis of the serine-rich C-terminal tail of the CCE domain of CRY2. This 43-residue C-terminal tail of CRY2 (from residues 570 to 612) contains 13 serine residues (30.2%), including a six-residue serine cluster (S570-S575) and the three phosphorylatable serine residues (S598, S599, and S605) identified in our MS experiment (Figure 1 ). We replaced serine residues with non-phosphomimetic alanines (S-to-A) or phosphomimetic aspartic acids (S-to-D) by site-specific mutagenesis, using the plasmid template encoding the GFP-CRY2 recombinant protein ( Figure 1D ). We also prepared transgenic plants expressing the serine-substitution mutants or the wildtype GFP-CRY2 control in the cry1cry2 double mutant background (Yu et al., 2009) . For simplicity, the transgenic lines expressing the wild-type GFP-CRY2 control and the GFP-CRY2 recombinant protein are referred to as the wild-type CRY2, whereas the transgenic lines expressing the serine-substitution GFP-CRY2 mutants and the respective GFP-CRY2 mutant proteins are referred to as xsA or xsD, where x indicates the number of serine residues within the 43-residue C-terminal tail of CRY2 that are substituted by A or D, respectively. For example, 4sA or 4sD refers to the GFP-CRY2 mutant proteins, of which four of the six serine residues of the serine cluster are replaced by alanines or aspartates, respectively. Similarly, 13sA or 13sD refers to the mutations, of which all 13 serine residues between residues 570 and 612 of the C-terminal tail of CRY2 are substituted by alanines or aspartates, respectively. The sequences of all 10 serine-substitution mutations of CRY2 analyzed in this report are shown in Figure 1D . To ensure that the phenotypic change of the serine-substitution mutants of CRY2is not due to a lower level of mutant protein expression, we selected transgenic lines that express GFP-CRY2 mutant proteins at a level slightly higher or comparable with that of the wild-type GFP-CRY2 control ( Figure 2A ). Figure 2 also shows that all CRY2 mutant proteins examined are located in the nucleus of Arabidopsis cells as the endogenous CRY2 or the wild-type GFP-CRY2 , suggesting that the mutant CRY2 proteins are not denatured. This result may not be surprising, because CCE is an unstructured domain of cryptochromes and mutations in this domain may not drastically disrupt the overall structure of the CRY2 holoprotein (Partch et al., 2005; Li, 2012) .
Mutations in the Serine Cluster Abolished the Phosphorylation Events Detectable by the Electrophoretic Mobility Upshift Assay
To examine the blue light-dependent phosphorylation of the serine-substitution mutants of CRY2 in the transgenic plants, etiolated seedlings without blue light treatment (D) or treated with blue light (B30, 60 mmol m À2 s À1 for 30 min) were analyzed by immunoblot probed with the anti-CRY2 antibody ( Figure 3) . We compared the blue light-dependent phosphorylation of different GFP-CRY2 recombinant proteins by the electrophoresis mobility shift assay (Shalitin et al., 2002) , in which both weak and the strong exposures of the same immunoblot are included to help distinguish subtle differences in the electrophoretic mobility of CRY2 in SDS-PAGE gels ( Figure 3) . We have previously shown that both the endogenous CRY2 protein and the wild-type GFP-CRY2 recombinant proteins undergo blue light-dependent phosphorylation and exhibit electrophoretic mobility upshift (Shalitin et al., 2002; Yu et al., 2007b Yu et al., , 2009 Zuo et al., 2011) . As expected, the wild-type GFP-CRY2 control exhibited the mobility upshift or protein phosphorylation in response to blue light ( 
CRY2 Phosphorylation
In contrast, no blue light-dependent mobility upshift was observed in any of the 10 serine-substitution mutants of CRY2, except 4sA/D, which might retain some residual mobility upshift ( Figure 3 ).
The results shown in Figure 3 revealed two interesting aspects of CRY2 phosphorylation. First, most CRY2 mutants examined, except 13sA/D, are not mutated in the phosphorylatable S598, S599, and S605 residues, and none of them showed a clear discernable electrophoretic mobility upshift ( Figure 3 ). This result, together with the fact that all those mutants contain mutations in the serine cluster (S570-S575), that proteins phosphorylated in serine clusters are prone to electrophoretic mobility upshift (Hereld et al., 1994) , and that protein phosphorylation do not always cause electrophoretic mobility upshift (Peck, 2006; Dephoure et al., 2013) , suggests that blue light induces two types of phosphorylation in the CRY2 protein: one occurs in the serine cluster that causes mobility upshift, whereas the other type occurs in residues outside the serine cluster that does not cause mobility upshift (prediction 1). Consistent with this prediction, the GFP-N563 fusion protein that lacks all 13 serine residues remains phosphorylated by 32 P without electrophoretic mobility upshift, although the phosphorylation activity of GFP-N563 is markedly weaker than that of the wild-type GFP- CRY2 control . Second, similar to the non-phosphomimetic Sto-A mutants, the phosphomimetic S-to-D mutants of CRY2 also lost blue lightdependent mobility upshift (Figure 3 ). This observation is in contrast to other phosphoproteins, such as PIF3.
The phosphomimetic S-to-D mutations of PIF3 mimic both mobility upshift and functional activity of the phosphorylated PIF3 protein (Ni et al., 2013) . Because it is well known that phosphomimetic mutations do not always reproduce the changes caused by protein phosphorylation (Peck, 2006; Dephoure et al., 2013) , we predict that both the nonphosphomimetic S-to-A mutations and the phosphomimetic S-to-D mutations of CRY2 result in the loss-of-function phenotype in not only mobility upshift but also the function of CRY2 (prediction 2).
The Phosphorylation-Deficient CRY2 Mutants Are Impaired in Blue Light-Dependent Proteolysis We tested the above two predictions first by analyses of how the serine-substitution mutations affect blue light-and phosphorylation-dependent degradation of CRY2 in vivo. We have shown previously that CRY2 undergoes blue lightdependent proteolysis that is dependent on the blue lightinduced phosphorylation and ubiquitination of the CRY2 protein (Shalitin et al., 2002; Yu et al., 2007a Yu et al., , 2009 Zuo et al., 2012) . We compared the kinetics of the blue light-dependent degradation of the mutant and the wild-type GFP-CRY2 proteins in etiolated seedlings exposed to blue light (Figure 4 ). Figure 4 shows that the endogenous CRY2 (WT) and the wild-type GFP-CRY2 control (CRY2) undergo blue light-dependent degradation, whereas the CRY2 mutant proteins containing progressively increased serine-substitution mutations were progressively more stable in blue light (Figure 4 ). For example, the degradation of the 4sA/D and 6sA/D mutants was detectable after prolonged exposure to blue light, although it was slower than the wild-type GFP-CRY2 ( Figure 4A and 4C). The CRY2 mutants that contain more serine substitutions, such as 8sA and 10sA, exhibited further decreased rates of proteolysis in comparison with that of 4sA and 6sA (Figure 4A and 4C) , and the 13sA mutant mutated in all 13 serine residues of the C-terminal tail of CRY2 exhibited no apparent proteolysis in response to blue light (Figure 4A and 4C) . This progressively decreased blue light sensitivity of the serine-substitution mutants, which is more apparent with longer blue light exposure ( Figure 4C , B180), suggests that most mutants except 13sA may remain weakly phosphorylated, ubiquitinated, and degraded in response to blue light. In other words, as we predicted (prediction 1), both the phosphorylation in the serine cluster detectable by mobility upshift assay and the phosphorylation in other residues undetectable by the mobility upshift assay contribute to the photobiochemical activities of CRY2. Similar to the non-phosphomimetic S-to-A mutations, the phosphomimetic S-to-D mutants of CRY2 also exhibited progressive impairment of the blue light-induced proteolysis of CRY2, although the effects of S-to-D mutations on the blue light-dependent proteolysis are generally weaker than that of the S-to-A mutations ( Figure 4B and 4D ). This result is consistent with our second prediction (prediction 2) that both the non-phosphomimetic S-to-A mutation and the phosphomimetic S-to-D mutants of CRY2 cause loss-of-function phenotypes.
The Phosphorylation-Deficient CRY2 Mutants Are Impaired in the Blue Light-Dependent Hypocotyl Inhibition Response
The observation that progressive increase of the number of serine-substitution mutations aggravates defects in blue lightdependent CRY2 degradation predicts that many or all serine residues in the serine-rich C-terminal tail of CRY2 are phosphorylatable to contribute to the photosensitivity of CRY2. Consistent with this hypothesis, we found that progressively increased serine substitutions of CRY2 also resulted in progressively decreased activity of CRY2 mutants to rescue the blue lightspecific long hypocotyl phenotype of the cry1cry2 mutant parent (Figures 5-7) . Figure 5 shows a clear trend that the transgenic seedlings expressing the CRY2 mutants containing progressively increased serine substitutions exhibited the phenotype progressively more similar to that of the cry1cry2 mutant parents (Figure 5B , Blue). For example, the seedlings expressing the CRY2 mutant that contains four serinesubstitution mutations (4sA) are slightly taller (P < 0.01) than that of the seedlings expressing the wild-type GFP-CRY2 control. In contrast, the seedlings expressing the CRY2 mutants containing six or more S-to-A mutations (6sA, 8sA, 10sA, and 13sA) were progressively and significantly taller than that expressing the wild-type GFP-CRY2 control (P < 0.001). No such difference was found in seedlings grown in darkness, or red light, or far red light, indicating that the phenotype difference is indeed due to the mutation of CRY2. Similar to the S-to-A mutants, the phosphomimetic S-to-D mutants of CRY2 also exhibited progressively reduced activity mediating blue light inhibition of hypocotyl elongation ( Figure 5C and 5D).
To confirm this observation, we analyzed the fluence rate response of the seedlings expressing the serine-substitution CRY2 mutants (Figure 6 ). Figure 6 shows that the cry1cry2 mutant exhibited no blue light inhibition of hypocotyl elongation in seedlings grown under most light intensities tested, except the highest fluence rates, likely due to the actions of phytochromes (Franklin et al., 2003) . The transgenic seedlings expressing the 4sA/D and 6sA/D mutant proteins exhibited either similar or slightly reduced hypocotyl lengths in comparison with the seedlings expressing the wild-type GFP-CRY2 control when grown in different fluence rates of blue light ( Figure 5, 4sA, 6sA, 4sD , and 6sD), indicating that those CRY2 mutants retain substantial physiological activity. In contrast, transgenic seedlings expressing the mutant CRY2 proteins that contain more than six serine substitutions (8sA, 10sA, 13sA, 8sD, 10sD, and 13sD) need over 100-fold higher fluence rate of blue light to achieve the same extent of hypocotyl inhibition ( Figure 6 ). This difference is not due to lower levels of mutant CRY2 expression because the steady-state level of those mutant CRY2 proteins is higher or comparable with that of the wild-type GFP-CRY2 control (Figure 2A) , and the mutant CRY2 proteins are more stable than the wild-type GFP-CRY2 control in etiolated seedlings exposed to blue light (Figure 4) . Therefore, as we predicted, the progressively increased serine substitutions progressively reduced the photosensitivity and activity of CRY2.
In addition to mediating blue light inhibition of hypocotyl elongation, CRY2 also mediates long-day promotion of floral initiation Molecular Plant CRY2 Phosphorylation . Figure 7 demonstrates that most S-to-A mutants tested, except 10sA and 13sA, were able to rescue the late-flowering phenotype of the cry1cry2 parent (Figure 7) . The transgenic plants expressing the 10sA and 13sA mutants showed statistically significant delay in flowering (P < 0.01), demonstrating again that increased serine substitutions of CRY2 aggravates the impairment of CRY2 activity to promote floral initiation in long-day photoperiods. The S-to-D mutation had a relatively weaker effect on the CRY2 activity than the S-to-A mutations. The transgenic plants expressing 10sD and 13sD mutants exhibited only slightly (P < 0.05) delayed flowering measured by days to flower, but showed no significant difference in leaf number at flowering (Figure 7 ). It is not clear why the serine-substitution mutations of CRY2 have more profound defects in mediating blue light inhibition of hypocotyl elongation than in promoting floral initiation. However, given that CRY2 interacts with multiple proteins to exert different functions in plant development (Wang et al., 2001; Yang et al., 2001; Liu et al., 2008 Liu et al., , 2011a Liu et al., , 2011b Zuo et al., 2011; Liu et al., 2013; Meng et al., 2013) , it is conceivable that different CRY2-interacting proteins regulating hypocotyl growth or floral initiation may be differentially affected by blue light-dependent serine phosphorylation or the serine-substitution mutations. This hypothesis remains to be tested.
DISCUSSION
In the present study, we investigated blue light-dependent phosphorylation of the GFP-CRY2 protein purified from plants by MS analyses, and identified at least three in vivo blue light-dependent phosphorylation sites (S598, S599, and S605) of CRY2. Further experiments are needed to elucidate all in vivo phosphorylation sites of CRY2. In addition, our analyses of the transgenic plants expressing the serine-substitution mutants of CRY2 showed that progressively increased serine substitutions resulted in progressive impairment of the regulation and physiological activities of CRY2 in response to blue light. These results are consistent with the hypothesis that the blue light-dependent phosphorylation of CRY2 determines the photosensitivity of this photoreceptor. It is noteworthy that the serine-substitution mutations may also result in structure perturbations to affect the photosensitivity of CRY2. For example, in yeast cells, the serinesubstitution mutant of CRY2 showed progressively reduced activity in the blue light-dependent interaction with the CRY2-signaling proteins CIB1 and SPA1 (Supplemental Figure 4) . Because yeast cells do not have bona fide CRY2 kinases, and CRY2 may not have autophosphorylation activity (Ozgur and Sancar, 2006; Yu et al., 2009) , the defect of CRY2 in interacting with CIB1 and SPA1 in yeast cells may result from conformation changes of the CRY2 mutants. However, because the CCE domain of cryptochromes is intrinsically unstructured (Partch et al., 2005), all serine-substitution mutants of CRY2 expressed normally and located correctly in the nucleus in transgenic plants (Figure 2) , and all mutants examined retained partial activities in the transgenic plants (Figures 5-7) , the reduced photosensitivity of serinesubstitution mutants of CRY2 in plants is more likely due to the reduced phosphorylation of those mutants.
Our study also discovered two previously unknown aspects of the blue lightdependent photo-phosphorylation of CRY2. First, our results suggest that CRY2 undergoes two types of phosphorylation: phosphorylation in the six-residue serine cluster, which causes electrophoretic mobility upshift, and phosphorylation in other residues (such as S598, S599, and S605), which does not result in electrophoretic mobility upshift. Additional studies are needed to verify this phenomenon and to elucidate the underling mechanistic implication of the two types of phosphorylation on the function and regulation of CRY2. Second, in contrast to the expectation that the phosphomimetic S-to-D mutations might cause gain-of-function effects to mimic the changes of protein phosphorylation, the S-to-D mutations of CRY2 showed a loss-of-function effect similar to that of the nonphosphomimetic S-to-A mutations in all phenotypes analyzed in our study, including light-dependent mobility upshift, protein stability, and physiological activities. It is known that phosphomimetic mutation does not always mimic or reproduce the changes introduced by protein phosphorylation (Dephoure et al., 2013) . For example, phosphomimetic S-to-D mutations of the mammalian mCRY1 caused a loss-of-function phenotype with respect to the transcription suppression activity (Sanada et al., 2004) . Whether or not a phosphomimetic mutation imitates the changes introduced by protein phosphorylation is dependent on the exact structural and functional roles of the respective phosphorylation event. For example, a phosphomimetic mutation may incline to reproduce the changes introduced by phosphorylation if the native protein is phosphorylated to produce a modified residue specifically recognized by another protein. On the other hand, a phosphomimetic mutation may be less likely to mimic the changes introduced by phosphorylation if the native protein is phosphorylated to establish a charge-dependent structural change. It has been previously proposed that blue light triggers separation of the PHR domain and the CCE domain to activate cryptochromes (Yang et al., 2000; Yu et al., 2007b) , and that phosphorylation of the CCE domain may facilitate such domain separation by a charge-dependent electrostatic repelling mechanism . According to this hypothesis, the number of negative charges introduced by light-dependent phosphorylation is important to the lightdependent structural change of cryptochromes. However, the negative charge carried by an aspartate (ca. À1 charge per residue) is at least 50% less than that introduced by phosphorylation (ca. À1.5 to À2 charges per residue) at about pH 7.2 estimated for the Arabidopsis nuclear compartment (Shen et al., 2013 ). This charge difference may explain the loss-offunction instead of gain-of-function phenotype of the phosphomimetic S-to-D mutations of CRY2. It would be informative to test whether the same phenomenon is true for CRY1. In this regard, it is particularly interesting that the truncated CRY1 or CRY2 recombinant proteins composed of the PHR/CNT domain in the absence of most (GFP-N563 of CRY2) or all (CNT1 of CRY1) of the CCE/CCT sequences He et al., 2015) , or composed of the CCE/CCT domain in the absence of the PHR sequences (GUS-CCT1 and GUS-CCT2) (Yang et al., 2000) , or composed of a short sequence from each of the two domains (NC80) are all reported to be active in transgenic plants. These seemingly perplexing observations may be explained by the phosphorylation-dependent domain separation model given that different CRY-signaling complexes interact with either or both domains of cryptochromes (Wang et al., 2001; Yang et al., 2001; Liu et al., 2008 Liu et al., , 2011a Liu et al., , 2011b Zuo et al., 2011; Liu et al., 2013; Meng et al., 2013) . This hypothesis may be further tested by elucidation of the specific structural elements of the PHR or CCE domain that interact with the known or presently unknown CRY-signaling protein or protein complexes.
MATERIALS AND METHODS
Plant Materials
Transgenic plants expressing the GFP-CRY2 fusion protein containing site-specific serine-substitution mutations of CRY2 were prepared in the cry1cry2 mutant background by the floral dip transformation method as described . The control transgenic plants expressing the wild-type GFP-CRY2 fusion protein in the cry1cry2 mutant background was described previously . To investigate the hypocotyl response of transgenic plants under different light conditions, seeds were surface sterilized for 15 min in 20% bleach and rinsed 3-4 times with sterile distilled water. About 50 seeds were placed on MS agar medium. After incubating in the dark at 4 C for 4 days, seeds were exposed to white light for 12 h before being transferred to temperature-controlled growth chambers, and grown under continuous blue, red, far red light, or in the dark at 22-24 C. After 6 days, the hypocotyl length of more than 20 seedlings was measured manually and the standard deviations were calculated. To measure the flowering time of transgenic plants, seeds were sown in soil and placed in the cold room for 4 days, and then placed in the long-day growth chamber.
The days to flowering and the total leaf number at flowering were counted as described .
Mass Spectrometry Analysis
The GFP-CRY2 fusion protein was purified by the GFP-trap method as described (Rothbauer et al., 2008) . The GFP-CRY2 protein fractionated by the gels shown in Figure 1A were excised, digested in the excised gel slices using trypsin, and subjected to MS analysis (Kaiser and Wohlschlegel, 2005; Kelstrup et al., 2012) . The peptide digests were desalted and fractionated online using a 75-mM inner diameter fritted fused silica capillary column with a 5-mM pulled electrospray tip packed in house with 17 cm of Luna C18(2) 3-mM reversed phase particles (Phenomonex). The gradient was delivered via an easy-nLC 1000 ultra high pressure liquid chromatography (UHPLC) system (Thermo Scientific). MS/MS spectra were collected on a Q-Exactive mass spectrometer (Thermo Scientific) (Michalski et al., 2011; Kelstrup et al., 2012) . Data analysis was performed using the ProLuCID and DTASelect2 algorithms as implemented in the Integrated Proteomics Pipeline -IP2 (Integrated Proteomics Applications, Inc., San Diego, CA) (Tabb et al., 2002; Xu et al., 2006; Cociorva et al., 2007) . Phosphopeptides were identified using a differential modification search that considered a mass shift of +79.9663 on serines, threonines, and tyrosines. All peptide-spectrum matches were evaluated by DTASelect2 and filtered to achieve a maximum false detection rate of 5% using a decoy database approach (Elias and Gygi, 2007) . Phosphosite localization confidence was assessed using the phosphoRS algorithm and a set of in-house scripts with all reported phosphopeptides possessing a localization probability score of greater than 99% (Taus et al., 2011) . Individual spectra were examined within the ProteoWizard suite's SeeMS (Kessner et al., 2008) . Label-free quantitation of the peptides was performed using the Skyline software package (MacLean et al., 2010) . Peak integration was carried out through manual interrogation of the data (MacLean et al., 2010; Schilling et al., 2012) . For each peptide, peak areas were summed for three isotopic peaks (M, M + 1, M + 2) to serve as the peptide's quantitative measure. For each dataset, phosphopeptide abundances were normalized to the amount of unmodified CRY2 detected in the sample. Unmodified CRY2 abundance was determined as the average of the integrated peak areas for identified CRY2 peptides, which were uniquely mapping, had no missed tryptic cleavage sites, and showed no evidence of phosphorylation.
Site-Specific Mutagenesis
The transgenes encoding the GFP-CRY2 fusion protein was used as the template to prepare all mutants described in this study. Amino acid substitutions of serine (S) to alanine (A) or serine (S) to aspartic acid (D) were introduced into the CRY2 coding sequence by site-directed mutagenesis. The QuickChange II site-specific mutagenesis kit (Stratagene, Inc) was used to prepare individual and combined mutants according to the manufacturer's instructions. All mutants were confirmed by DNA sequencing. Site-mutated fragments were cloned into pEGAD vector and fused to the C-terminus of the GFP sequence to generate the following mutations of CRY2: 4sA (S570A, S571A, S572A, S573A), 6sA (S570A, S571A, S572A, S573A, S574A, S575A), 8sA (S570A, S571A, S572A, S573A, S574A, S757A, S580A, S582A), 10sA (S570A, S571A, S572A, S573A, S574A, S575A, S580A, S582A, S584A, S587A) 13sA (S570A, S571A, S572A, S573A, S574A, S575A, S580A, S582A, S584A, S587A, S598A, S599A, S605A). A similar method was used to prepare the 4sD (S570D, S571D, S572D, S573D), 6sD (S570D, S571D, S572D, S573D, S574D, S575D), 8sD (S570D, S571D, S572D, S573D, S574D, S575D, S580D, S582D), 10sD (S570D, S571D, S572D, S573D, S574D, S575D, S580D, S582D, S584D, S587D) and 13sD (S570D, S571D, S572D, S573D, S574D, S757D, S580D, S582D, S584D, S587D, S598D, S599D, S605D) mutant constructs. The recombinant CRY2 transgenes expressing the wild-type or mutant GFP-CRY2 fusion proteins were transformed to the cry1cry2 double mutant (Col accession).
The primers (F, forward; R, reverse) used in the site-specific mutagenesis of the CRY2 coding sequence were as follows: 
Yeast Two-Hybrid Assays
The coding sequence of CRY2 was cloned into bait vector pBridge, and CIB1 and SPA1 were cloned into prey vector pGADT7 as reported previously (Liu et al., 2008 (Liu et al., , 2011a Zuo et al., 2011) . The mutated fragments of CRY2 were amplified from transgenes encoding 4sA, 6sA, 8sA, 10sA, and 13sA proteins generated by the sense (TGTATCGCCGGAATTCA TGAAGATGGACAAAAAGACTA) and antisense (TTGGCTGCAGGTCG ACTTTGCAACCATTTTTTCCCAA) primers (with the EcoR I and Sal I restriction sites), subcloned into the EcoR I and Sal I sites of bait vector pBridge using the Clontech Infusion PCR cloning kit (Clontech) and confirmed by DNA sequencing. The bait and the prey plasmids were cotransformed into the yeast strain AH109. The protein-protein interaction was analyzed using the histidine auxotrophy assay, by which yeast colonies were grown in duplicate onto HisÀ and His+ plates. One duplicate was grown under blue light (25 mol m À2 s
À1
), at 28 C for 2-3 days; the second duplicate was wrapped in aluminum foil to block the light and grown in the same conditions. Liquid assays were as previously described (Zuo et al., 2011) .
Protein Analyses
To analyze blue light-induced CRY2 degradation, seedlings were grown on MS medium for 6 days in the dark, and exposed to blue light (60 mmol m À2 s À1 ) for the indicated time. Total proteins were extracted, fractionated in 10% SDS-PAGE gels, and transferred to nitrocellulose membranes for immunoblots. The blots were probed by anti-CRY2 antibody or anti-HSP90 antibody for the loading control. The immunoblot signals were quantified using ImageJ (http://rsb.info.nih.gov/ij/); the relative level of CRY2 was calculated by normalization of the blue light signal with the dark control as described .
To investigate blue light-induced CRY2 phosphorylation, seedlings were grown on MS solid medium for 6 days in the dark and then exposed to blue light (60 mmol m À2 s
À1
) for 30 min. To show the fine resolution of migration alterations resulting from protein phosphorylation, a low voltage (120 V) was used and the gel was run for about 4 h before transferring to nitrocellulose membranes for immunoblots. The blot was probed with anti-CRY2 antibody to show the CRY2 level and the mobility upshift of CRY2 indicates phosphorylation.
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